These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21263385)

  • 1. A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia.
    Christaki E; Opal SM; Keith JC; Kessimian N; Palardy JE; Parejo NA; Tan XY; Piche-Nicholas N; Tchistiakova L; Vlasuk GP; Shields KM; Feldman JL; Lavallie ER; Arai M; Mounts W; Pittman DD
    Shock; 2011 May; 35(5):492-8. PubMed ID: 21263385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.
    van Zoelen MA; Schouten M; de Vos AF; Florquin S; Meijers JC; Nawroth PP; Bierhaus A; van der Poll T
    J Immunol; 2009 Apr; 182(7):4349-56. PubMed ID: 19299735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?
    Christaki E; Lazaridis N; Opal SM
    Curr Opin Infect Dis; 2012 Jun; 25(3):304-11. PubMed ID: 22327468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
    Susa Y; Masuda Y; Imaizumi H; Namiki A
    Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.
    Lutterloh EC; Opal SM; Pittman DD; Keith JC; Tan XY; Clancy BM; Palmer H; Milarski K; Sun Y; Palardy JE; Parejo NA; Kessimian N
    Crit Care; 2007; 11(6):R122. PubMed ID: 18042296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
    Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
    J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.
    Liliensiek B; Weigand MA; Bierhaus A; Nicklas W; Kasper M; Hofer S; Plachky J; Gröne HJ; Kurschus FC; Schmidt AM; Yan SD; Martin E; Schleicher E; Stern DM; Hämmerling G Gü; Nawroth PP; Arnold B
    J Clin Invest; 2004 Jun; 113(11):1641-50. PubMed ID: 15173891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice.
    van Zoelen MA; Schmidt AM; Florquin S; Meijers JC; de Beer R; de Vos AF; Nawroth PP; Bierhaus A; van der Poll T
    J Infect Dis; 2009 Sep; 200(5):765-73. PubMed ID: 19627249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
    Rijneveld AW; Weijer S; Bresser P; Florquin S; Vlasuk GP; Rote WE; Spek CA; Reitsma PH; van der Zee JS; Levi M; van der Poll T
    Crit Care Med; 2006 Jun; 34(6):1725-30. PubMed ID: 16625114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of monoclonal antibodies against different epitopes on extracellular domain of human receptor for advanced glycation end product.
    Zhu P; Tang L; Zhao SC; Lu X; Hou FF; Fu N
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):129-32. PubMed ID: 14965808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
    Jensen LJ; Denner L; Schrijvers BF; Tilton RG; Rasch R; Flyvbjerg A
    J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD16 inhibition increases host survival in a murine model of severe sepsis.
    Zhang D; He J; Shen M; Wang R
    J Surg Res; 2014 Apr; 187(2):605-9. PubMed ID: 24331941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.
    Eskandari MK; Bolgos G; Miller C; Nguyen DT; DeForge LE; Remick DG
    J Immunol; 1992 May; 148(9):2724-30. PubMed ID: 1315357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia.
    Rijneveld AW; Florquin S; Hartung T; Speelman P; van der Poll T
    J Infect Dis; 2003 Jul; 188(2):282-5. PubMed ID: 12854084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Important role for CC chemokine ligand 2-dependent lung mononuclear phagocyte recruitment to inhibit sepsis in mice infected with Streptococcus pneumoniae.
    Winter C; Herbold W; Maus R; Länger F; Briles DE; Paton JC; Welte T; Maus UA
    J Immunol; 2009 Apr; 182(8):4931-7. PubMed ID: 19342672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytoprotective effects of endogenous activated protein C reduce activation of coagulation during murine pneumococcal pneumonia and sepsis.
    Schouten M; van 't Veer C; Poulussen N; Meijers JC; Levi M; Esmon CT; van der Poll T
    Thromb Res; 2015 Mar; 135(3):537-43. PubMed ID: 25586194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
    Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited role of the receptor for advanced glycation end products during Streptococcus pneumoniae bacteremia.
    Achouiti A; de Vos AF; de Beer R; Florquin S; van 't Veer C; van der Poll T
    J Innate Immun; 2013; 5(6):603-12. PubMed ID: 23774862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a young mouse model and identification of an allelic variation of zmpB in complicated pneumonia caused by Streptococcus pneumoniae.
    Hsieh YC; Tsao PN; Chen CL; Lin TL; Lee WS; Shao PL; Lee CY; Hsueh PR; Huang LM; Wang JT
    Crit Care Med; 2008 Apr; 36(4):1248-55. PubMed ID: 18379252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.